IU Research Targets Chemo Side Effects

Posted: Updated:
(Image courtesy of Indiana University.) Mark Kelley has three decades of experience as a cancer researcher. (Image courtesy of Indiana University.) Mark Kelley has three decades of experience as a cancer researcher.
INDIANAPOLIS -

A $2.9 million National Cancer Institute grant will support Indiana University School of Medicine research into some of the negative side effects of chemotherapy. Pediatric Oncology Professor Mark Kelley was awarded the funding to investigate chemotherapy-induced neuropathy, which currently has no effective treatment or prevention.

Previous efforts by Kelley and colleagues have shown some promise. "We hypothesize that APE1 is a critical protein for protecting neurons from cancer therapies and that augmenting its DNA repair activity will prevent and reverse chemotherapy-induced alterations in sensory neuronal function," he said. In the lab and in mice, IU says past studies have shown that boosting APE1 protein repair levels decreases neurotoxicity.

You can connect to more about the course of study by clicking here.

  • Perspectives

    • Increasing Women Leaders in Companies and Associations

      As members of an industry largely populated by male professionals, we see firsthand the need for more diversity. As Katie Culp, president of KSM Location Advisors, noted in a recent blog, diversity leads to better business decisions.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Coal Loading Facility Planned For Princeton

      A subsidiary of Denver-based Hallador Energy Co. (Nasdaq: HNRG) has announced plans to construct a new truck-to-rail coal loading facility near Princeton. Sunrise Coal LLC in Terre Haute says the facility, known as the Princeton Loop, is expected to be complete in the spring of 2018. 

    • Opioid Withdrawal Treatment Lands FDA Clearance

      The U.S. Food and Drug Administration has given clearance for a medical device developed in Indiana to help treat symptoms of opioid withdrawal. The device, known as the NSS-2 BRIDGE, was created by Innovative Health Solutions Inc. in Versailles.

    • The Critical Importance of Shared Vision

      Vision statements and vision exercises - many organizations have them, but do they work? Business literature on the power of vision exists in abundance. But the real challenge about this strategic element is achieving and acting on a truly shared vision. Make no mistake, the power of shared vision moves mountains, and it's worth the required effort. Here are some thoughts to consider.

    • Holcomb Makes Board Appointments

      Governor Eric Holcomb has made another round of appointments to various boards and commissions. They Include the Indiana Public Defender Commission, the Indiana Tourism Council and the Indiana State Fair Board.

    • On-Air

      Find out when and where you can watch and listen to our reports.